Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 45 | $72,447,686 |
Sells | 106 | $271,602,767 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,041,700 | 2.4 | 2,500,080 | I |
26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 242,200 | 2.4 | 581,280 | I |
26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,841,100 | 2.4 | 4,418,640 | I |
29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 58,000 | 2.09 | 121,220 | I |
29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 442,000 | 2.09 | 923,780 | I |
29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 250,000 | 2.09 | 522,500 | I |
29 Jun 2023 16:46 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 27 Jun 2023 | Purchase | 125,000 | 2.09 | 261,250 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 139,166 | 18.32 | 2,549,521 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 1,195,683 | 18.32 | 21,904,913 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 3,128 | 19.82 | 61,997 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 26,872 | 19.82 | 532,603 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 18,922 | 19.96 | 377,683 | I |
29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 162,576 | 19.96 | 3,245,017 | I |
31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
10 Nov 2022 16:44 | CMPX | Compass Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 08 Nov 2022 | Purchase | 402,000 | 3.21 | 1,290,420 | I |
20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 1,000,000 | 22.14 | 22,140,000 | I |
20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 33,300 | 22.14 | 737,262 | I |
25 Jan 2024 16:28 | EWTX | Edgewise Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
17 Aug 2023 16:40 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 15 Aug 2023 | Sale | 535,534 | 0.75 | 401,650 | I |
17 Aug 2023 16:40 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 15 Aug 2023 | Sale | 248,819 | 0.75 | 186,614 | I |
17 Aug 2023 16:40 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 15 Aug 2023 | Sale | 38,327 | 0.75 | 28,745 | I |
02 Aug 2023 17:05 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 31 Jul 2023 | Sale | 153,078 | 3 | 459,234 | I |
02 Aug 2023 17:05 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 31 Jul 2023 | Sale | 29,700 | 3 | 89,100 | I |
02 Aug 2023 17:05 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 31 Jul 2023 | Sale | 26,622 | 3 | 79,866 | I |
27 Jul 2023 16:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 25 Jul 2023 | Sale | 4,700 | 2.92 | 13,724 | I |
27 Jul 2023 16:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 25 Jul 2023 | Sale | 26,700 | 2.92 | 77,964 | I |
27 Jul 2023 16:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 25 Jul 2023 | Sale | 7,800 | 2.92 | 22,776 | I |
17 Jul 2023 16:13 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Jul 2023 | Sale | 132,100 | 2.4 | 317,040 | I |
17 Jul 2023 16:13 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Jul 2023 | Sale | 52,800 | 2.4 | 126,720 | I |
17 Jul 2023 16:13 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Jul 2023 | Sale | 9,800 | 2.4 | 23,520 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 17 Apr 2023 | Sale | 8,878 | 1.97 | 17,490 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 17 Apr 2023 | Sale | 3,551 | 1.97 | 6,995 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 17 Apr 2023 | Sale | 660 | 1.97 | 1,300 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 14 Apr 2023 | Sale | 28,110 | 1.86 | 52,285 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 14 Apr 2023 | Sale | 11,245 | 1.86 | 20,916 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 14 Apr 2023 | Sale | 2,091 | 1.86 | 3,889 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Apr 2023 | Sale | 9,459 | 1.82 | 17,215 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Apr 2023 | Sale | 3,784 | 1.82 | 6,887 | I |
17 Apr 2023 17:28 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 13 Apr 2023 | Sale | 703 | 1.82 | 1,279 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 12 Apr 2023 | Sale | 1,603 | 1.81 | 2,901 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 12 Apr 2023 | Sale | 641 | 1.81 | 1,160 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 12 Apr 2023 | Sale | 119 | 1.81 | 215 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 11 Apr 2023 | Sale | 9,459 | 1.82 | 17,215 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 11 Apr 2023 | Sale | 3,784 | 1.82 | 6,887 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 11 Apr 2023 | Sale | 703 | 1.82 | 1,279 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 10 Apr 2023 | Sale | 34,745 | 1.79 | 62,194 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 10 Apr 2023 | Sale | 13,899 | 1.79 | 24,879 | I |
12 Apr 2023 18:44 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 10 Apr 2023 | Sale | 2,584 | 1.79 | 4,625 | I |
07 Apr 2023 16:42 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 06 Apr 2023 | Sale | 6,558 | 2 | 13,116 | I |
07 Apr 2023 16:42 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 06 Apr 2023 | Sale | 2,620 | 2 | 5,240 | I |
07 Apr 2023 16:42 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 06 Apr 2023 | Sale | 487 | 2 | 974 | I |
07 Apr 2023 16:42 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 05 Apr 2023 | Sale | 63,058 | 2.18 | 137,466 | I |
07 Apr 2023 16:42 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 05 Apr 2023 | Sale | 25,220 | 2.18 | 54,980 | I |
07 Apr 2023 16:42 | GLTO | Galecto Inc | ORBIMED ADVISORS LLC | 10% | 05 Apr 2023 | Sale | 4,687 | 2.18 | 10,218 | I |
20 Dec 2023 18:28 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 18 Dec 2023 | Sale | 1,724 | 59.24 | 102,130 | D |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 57,100 | 56.75 | 3,240,425 | I |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 228,500 | 56.75 | 12,967,375 | I |
15 Dec 2023 18:04 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 147,600 | 56.75 | 8,376,300 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 100 | 57.73 | 5,773 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 14 Dec 2023 | Sale | 100 | 57.73 | 5,773 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 14,100 | 58.56 | 825,696 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 36,400 | 58.56 | 2,131,584 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 13 Dec 2023 | Sale | 56,200 | 58.56 | 3,291,072 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 9,300 | 60.16 | 559,488 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 3,600 | 60.16 | 216,576 | I |
14 Dec 2023 17:44 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Dec 2023 | Sale | 14,400 | 60.16 | 866,304 | I |
20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 10,986 | 36 | 395,496 | I |
20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 43,944 | 36 | 1,581,984 | I |
20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 28,404 | 36 | 1,022,544 | I |
17 Feb 2023 16:43 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Feb 2023 | Purchase | 14,329 | 23 | 329,567 | I |
17 Feb 2023 16:43 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Feb 2023 | Purchase | 37,049 | 23 | 852,127 | I |
17 Feb 2023 16:43 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Feb 2023 | Purchase | 57,318 | 23 | 1,318,314 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 05 May 2023 | Purchase | 490,511 | 2.82 | 1,383,241 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 05 May 2023 | Purchase | 490,512 | 2.82 | 1,383,244 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 04 May 2023 | Purchase | 83,459 | 2.75 | 229,512 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 04 May 2023 | Purchase | 312,991 | 2.75 | 860,725 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 04 May 2023 | Purchase | 83,459 | 2.75 | 229,512 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 02 May 2023 | Purchase | 58,826 | 2.67 | 157,065 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 02 May 2023 | Purchase | 220,610 | 2.67 | 589,029 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 02 May 2023 | Purchase | 58,826 | 2.67 | 157,065 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 01 May 2023 | Purchase | 124,545 | 2.62 | 326,308 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 01 May 2023 | Purchase | 467,068 | 2.62 | 1,223,718 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 01 May 2023 | Purchase | 124,544 | 2.62 | 326,305 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 28 Apr 2023 | Purchase | 60,997 | 2.55 | 155,542 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 28 Apr 2023 | Purchase | 228,754 | 2.55 | 583,323 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 28 Apr 2023 | Purchase | 60,998 | 2.55 | 155,545 | I |
15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 29,400 | 44.01 | 1,293,894 | I |
15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 220,600 | 44.01 | 9,708,606 | I |
17 Sep 2024 20:13 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Sep 2024 | Purchase | 250,000 | 16 | 4,000,000 | I |
17 Sep 2024 20:13 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Sep 2024 | Purchase | 500,000 | 16 | 8,000,000 | I |
04 Oct 2023 17:36 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 03 Oct 2023 | Sale | 700 | 9.02 | 6,314 | I |
04 Oct 2023 17:36 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 02 Oct 2023 | Sale | 7,614 | 9.08 | 69,135 | I |
03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 03 May 2024 | Sale | 4,674 | 14.03 | 65,576 | I |
03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 02 May 2024 | Sale | 8,842 | 14.01 | 123,876 | I |
03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 01 May 2024 | Sale | 15,690 | 14.02 | 219,974 | I |
26 Apr 2024 17:01 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 24 Apr 2024 | Sale | 1,781 | 14.06 | 25,041 | I |
23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 23 Apr 2024 | Sale | 21,791 | 14.29 | 311,393 | I |
23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 22 Apr 2024 | Sale | 24,609 | 14.05 | 345,756 | I |
23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 19 Apr 2024 | Sale | 18,253 | 14.02 | 255,907 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)